Dow Corning Healthcare, a global leader in medical silicone technology and innovation, will be present to meet with members of the pharmaceutical and biopharmaceutical industry during the BioProcess International (BPI) Conference and Exhibition in Boston, Sept 16-19, booth #601.
Dow Corning has served the industry for more than 50 years with Dow Corning® brand Pharmaceutical Tubing, Dow Corning® Fabricated Tubing Assemblies (FTAs) and Dow Corning® Laboratory Tubing product lines.
Customers benefit from Dow Corning’s unique, fully vertically integrated supply chain that aids in strict change control procedures and management. From silicon metal production, through a variety of intermediate processes, all the way through to tubing extrusion and packaging, Dow Corning owns and controls the materials and processes used in the production of Dow Corning Pharmaceutical Tubing and FTAs. Dow Corning Healthcare products are manufactured at its Healthcare Industries Materials Site (HIMS) in Hemlock, MI and it is United States Food and Drug Administration registered for both device and active pharmaceutical ingredient production (CFN 1816403). Dow Corning Pharmaceutical Tubing and FTAs are extruded and molded from Silastic® brand BioMedical Grade elastomers that exceed United States Pharmacopeia (USP®) Class VI requirements and are manufactured following the principles of FDA 21 CFR 210/211 cGMPs for Pharmaceutical products.
“We repeatedly hear from our customers that safety and security in the production process is critical,” says Yanli Zhang, Dow Corning Healthcare Pharmaceutical Processing market leader. “I am very proud of Dow Corning’s manufacturing operations and the high standards of change control we manage. These are crucial elements of what we promise to our industry partners who trust us to meet their needs exactly. Offering safety and security of supply to our customers is our number one priority.”
During the BPI conference, Dow Corning experts will also share with manufacturers its latest findings about particulates and extractables. With this research program, Dow Corning continues to study and communicate impacts on and methods for the three C’s of tubing particulates – capture, count and characterization
Learn more about Dow Corning’s Fascinating Silicone™ for healthcare.
About Dow Corning Healthcare
Dow Corning has more than 50 years of experience serving the health care related industries to improve the quality of life, transform patient care, and pioneer next generation innovation through silicone advancements. Dow Corning offers materials that are beneficial in pharmaceutical and biopharmaceutical processing as well as drug delivery, wound and scar management and medical device fabrication.
Source: http://www.dowcorning.com/